Stay updated on Risankizumab vs Secukinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page
- Check4 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new line '2017 ( U.S. NIH Grant/Contract )' was added. The site revision was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.6.5 has been added, replacing the previous Revision: v3.6.4. This is a platform version update and does not change the study content on the page.SummaryDifference0.0%

- Check53 days agoChange DetectedNow shows Revision: v3.6.4 in the data-sharing section. This reflects an update to the underlying software version used for IPD data sharing.SummaryDifference0.0%

- Check74 days agoChange DetectedThe revision label on the page updated to v3.6.3, indicating a behind-the-scenes update to the platform. This change does not alter the study details or user-facing content.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page footer now displays Revision: v3.6.2, replacing the previous v3.6.0.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page now indicates recruitment has closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also adjusts the Intervention/Treatment heading and updates the revision to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Risankizumab vs Secukinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.